Navigation Links
Palatin Technologies Refutes Competitive Technologies Contention of Material Breach
Date:9/12/2007

CRANBURY, N.J., Sept. 12 /PRNewswire-FirstCall/ -- Palatin Technologies, Inc. (Amex: PTN) stated today that the press release issued on September 11, 2007 by Competitive Technologies, Inc. (Amex: CTT) relating to a material breach and termination of a license agreement was false and misleading.

The press release issued by CTT stated that "Competitive Technologies Terminates License Agreement with Palatin Technologies." However, the Notice of Termination sent by CTT to Palatin the day before expressly stated Palatin had "sixty (60) days from the date of this letter to cure" the alleged defaults. The statement made by CTT that the underlying license agreement between Palatin and CTT had been terminated is false and misleading.

The underlying Palatin/CTT license agreement relates to patent rights for compounds and methods used for treatment of sexual dysfunction, including a compound called melanotan-II (MT-II) or PT-14. Palatin ceased development of PT-14 in 2000 and has no plans for further development of the compound. Palatin's bremelanotide compound was independently developed and patented by Palatin, and Palatin believes that bremelanotide is not covered by any of CTT's patents or patent rights. Whether bremelanotide is subject to the license agreement is an issue in an ongoing arbitration proceeding initiated by CTT in June 2006.

Palatin received a Notice of Termination on this matter from CTT in the late afternoon of September 10, 2007. The Notice of Termin
'/>"/>

SOURCE Palatin Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Barriers will not stop convergence of medical technologies
2. Merge Technologies net loss doubles to $10.1M
3. Making deals with evolving technologies in mind
4. Third Wave Technologies to raise $14.9M through private debt
5. Meier joins Broadlook Technologies as COO
6. Platypus Technologies secures $450K SBIR grant
7. Napier joins board of Third Wave Technologies
8. aOva Technologies raises $3 million
9. Consumer, business technologies face same challenges
10. Promega to get early access to WARF technologies under new agreement
11. Linda Weber to run Fiservs Interactive Technologies unit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... ... August 27, 2015 , ... Proove ... new data on the relationship of genetics and hypertension at the International ... Disease in Vancouver, British Columbia, Canada. The event, which boasts an extensive overview ...
(Date:8/26/2015)... Aug. 26, 2015  The Diabetes Research Institute ... of Miami Miller School of Medicine, announced today ... to test for the first time a novel ... This FDA approved Phase I/II study builds upon ... is an important first step toward the development ...
(Date:8/26/2015)... After litigating and negotiating patent infringement ... P2i United States patent RE43,651 (the ... the United States without any admission or ... party. As a result of the parties, settlement, the US ... dismissed the case without prejudice. Under ...
(Date:8/25/2015)... ... August 25, 2015 , ... A new ... cancerous is described by University of Illinois researchers in the Journal of ... , In “ Breast cancer diagnosis using spatial light interference microscopy ,” published ...
Breaking Biology Technology:Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 2Proove Biosciences Presents Ground-Breaking Data on Genetics and Heart Disease at 20th World Congress on Heart Disease 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 2Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 3Diabetes Research Institute Successfully Transplants First Patient In Pilot BioHub Trial 4P2i Settles United States Litigation 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 2New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 3New Optical Method Promises Faster, More Accurate Diagnosis of Breast Cancer 4
... note: Recently the Wisconsin Technology Network sat down ... Technology Council , to discuss the basic tenants and ... Wisconsins technology space grow. This is the first portion ... faces and how the Wisconsin Technology Council is working ...
... Sonic Foundry Inc . has introduced two ... distribute rich media for a variety of uses. ... real-time, rich media technology, are intended to enable ... needed for corporate communications, Web-based education, online training, ...
... Camtronics Medical Systems has announced that its ... with six terabytes of storage for digital cardiovascular images ... about two years worth of study results, which clinicians ... hospital or over the Web from outreach clinics. In ...
Cached Biology Technology:WTN exclusive interview with Tom Still, Wisconsin Technology Council 2WTN exclusive interview with Tom Still, Wisconsin Technology Council 3WTN exclusive interview with Tom Still, Wisconsin Technology Council 4WTN exclusive interview with Tom Still, Wisconsin Technology Council 5Sonic Foundry announces new Mediasite products 2
(Date:8/18/2015)... , Aug. 18, 2015  Navitas ... key contributor to the Submission Content Management ... IRISS, a non-profit forum. Dedicated to the Implementation ... a neutral platform for industry, vendors, health ... information and work towards a standard method ...
(Date:8/12/2015)... 12, 2015   MedNet Solutions , an innovative ... of clinical research, is proud to announce that ... SaaS-based eClinical technology platform, has led the way to ... quarters of 2015.   Q2 2015 and Q1 2015 ... by contract value sold in the company,s 15 year ...
(Date:8/12/2015)... , Aug. 12, 2015  Synaptics Inc. ... human interface solutions, today announced that four of ... Match-in-Sensor solution, have officially been named FIDO Certified™ ... part of the certification, Synaptics, Natural ID™ fingerprint ... Universal Authentication Framework (UAF) standard and are interoperable ...
Breaking Biology News(10 mins):Navitas, a Key Contributor in IRISS Forum Webinar 2Navitas, a Key Contributor in IRISS Forum Webinar 3MedNet Solutions Experiences Explosive Corporate Growth 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 2Synaptics Announces FIDO Certification of Natural ID Fingerprint Solutions 3
... (April 6, 2009) Cell Press, an imprint of Elsevier, ... well as Current Biology and The American ... Library Association,s (SLA) Top 100 Journals in Biology and Medicine ... compiled by the 680-plus members of the SLA,s Biomedical and ...
... experimental vaccine that triggers the patient,s immune system to ... promise for the treatment of early lung cancer. ... the vaccine called MAGE-A3 Antigen-Specific Cancer Immunotherapeutic, which is ... Rush is one of only five hospitals in Illinois ...
... systems for splitting water into hydrogen and oxygen, driven ... science today, underpinning the long term potential of hydrogen ... exist today are very inefficient and often require additional ... is important to establish new mechanisms by which water ...
Cached Biology News:3 prominent Cell Press journals named among the 100 most influential journals in past 100 years 2Novel lung cancer vaccine shows promise in fighting early-stage lung cancer 2Weizmann Institute scientists develop a unique approach for splitting water into hydrogen and oxygen 2Weizmann Institute scientists develop a unique approach for splitting water into hydrogen and oxygen 3
Mouse monoclonal [050-04] to C2 ( Abpromise for all tested applications). entrezGeneID: 717 SwissProtID: P06681...
Rabbit polyclonal to Bag5 ( Abpromise for all tested applications). entrezGeneID: 9529 SwissProtID: Q9UL15...
Rabbit polyclonal to Tryptophanyl tRNA synthetase ( Abpromise for all tested applications). Antigen: Recombinant full length protein (Human): Tryptophanyl tRNA synthetase Entrez Gene ID: 745...
WTAP Antibody...
Biology Products: